- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Lilly launches global Alzheimer's campaign with Julianne Moore | ||
| Fr | John Morikis joins Johnson & Johnson's board of directors | ||
| Do | Novartis to acquire Tourmaline Bio in a deal worth $1.4bn | ||
| Do | Resolution Therapeutics appoints Lucy Singah as CFO and Daniel Kennedy as CBO | ||
| Mi | Novo Nordisk to cuts 9,000 jobs in an effort to streamline its operations | ||
| Mi | Inizio appoints Ryan Quigley as new CEO | ||
| Di | Lilly and Circle Pharma agree to collaborate on new oral macrocycle therapies | ||
| Di | Emma Bush appointed as CNX Therapeutics' Vice President, Commercial | ||
| 08.09. | Invivyd working with FDA towards potential Biologics License Application for COVID-19 | ||
| 08.09. | Adam Raff appointed as Orbital Therapeutics' Senior Vice President, Clinical Development | ||
| 08.09. | Atlantic currents: the changing tide of health policy in the US and Europe | ||
| 05.09. | PhotoPharmics' new advisory board to guide launch of FDA Breakthrough device for Parkinson's | ||
| 05.09. | TRIMTECH Therapeutics establishes Scientific Advisory Board | ||
| 04.09. | Genentech starts construction on manufacturing facility in North Carolina, US | ||
| 04.09. | David Weinreich appointed as Merck KGaA's Global Head of R&D and CMO, Healthcare | ||
| 03.09. | UK's first new type of antibiotic for UTIs in nearly 30 years approved by MHRA | ||
| 03.09. | Zack Lentz appointed as Chief Commercial Officer at OPEN Health | ||
| 02.09. | EMA orphan drug designation given to ReAlta for graft-versus-host disease therapy | ||
| 02.09. | Matt Kiely appointed as Genmab General Manager in the UK | ||
| 01.09. | Lilly reports survival benefit with Verzenio in high-risk early breast cancer | ||
| 01.09. | Sanofi appoints Lisa Sha as general manager, vaccines in the UK & Ireland | ||
| 29.08. | FDA approves Pfizer and BioNTech's jab for COVID-19 | ||
| 29.08. | Executive VP and President of Lilly Neuroscience to retire | ||
| 28.08. | FDA approves Teva's Ajovy to prevent episodic migraine in paediatric patients | ||
| 28.08. | IQVIA and Veeva agree on long-term clinical and commercial partnerships |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .